Barclays Reiterates Equalweight Rating on CME Group (CME)
Tweet Send to a Friend
Barclays analyst Benjamin Budish reiterated an Equalweight rating and $228.00 price target on CME Group (NASDAQ: CME).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


